Skip to main content
. 2024 Jun 26;71(12):1097–1101. doi: 10.1507/endocrj.EJ24-0177

Table 2 . The experimental condition and phenotype of AGRKO under glucocorticoid administration.

Author Background Treatment Fat mass Glucose tolerance
Bose et al. [24] C57BL/6 10mg/kg dexamethasone for 2 weeks Increase No change
Shen et al. [26] N.D. 3mg/kg dexamethasone every other day for 2 months No change Improve
Dalle et al. [27] C57BL/6J (CreERT2) 100ug/mL corticosterone for 4 weeks Increase Improve
Hayashi et al. [21] C57BL/6 50ug/mL corticosterone for 2 weeks Increase Improve

N.D.; not described.